Navigation Links
Boca Pharmacal Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets
Date:1/27/2011

CORAL SPRINGS, Fla., Jan. 27, 2011 /PRNewswire/ -- Boca Pharmacal, Inc. announced today that the U.S. Food and Drug Administration (FDA) approval and commercial launch of Hydrocodone Bitartrate and Acetaminophen (5mg/300mg, 7.5mg/300mg and 10mg/300mg) Boca's generic version of Victory Pharma's Xodol®. Hydrocodone Bitartrate and Acetaminophen is indicated for the relief of moderate to moderately severe pain

(Logo: http://photos.prnewswire.com/prnh/20110127/FL37887LOGO)

ABOUT BOCA PHARMACAL

Boca Pharmacal is a privately held pharmaceutical research and development company with full marketing and distribution.  Founded in 1998 the company has focused on ability to offer lower volume items that may have been overlooked by some of the larger generic companies.  Boca markets over 30 products and has a robust pipeline of lower cost generic alternatives.


'/>"/>
SOURCE Boca Pharmacal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
2. Mission Pharmacal Launches New Vitamin B6-Rich Prescription Prenatal Vitamin, CitraNatal(R) B-Calm
3. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
4. China Sky One Medical Receives Medical Industry Awards
5. Lakewood-Amedex Inc. Receives Notice of Allowance on Three US Patent Applications Relating to Treatment of Hemolytic Uremic Syndrome
6. Varian Medical Systems Security and Inspection Products Group Receives Largest Single Order for IntellX Systems
7. Crestwood Technology Group Receives Silver Boeing Performance Excellence Award
8. HeartWare Receives Third Patient Allotment From FDA - Authorizing 94 Additional Patients - Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial
9. Mylans Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets
10. Aribex CEO Receives Utah Governors Medal
11. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Lamivudine and Zidovudine Tablets, 30 mg/60 mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
Breaking Medicine News(10 mins):